Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-08
DOI
10.1007/s10557-019-06876-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis
- (2018) Thomas A. Treibel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction
- (2017) G. Michael Felker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biological Phenotypes of Heart Failure With Preserved Ejection Fraction
- (2017) Gavin A. Lewis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction
- (2017) Erik B. Schelbert et al. JAMA Cardiology
- Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection FractionClinical Perspective
- (2016) Masaru Obokata et al. CIRCULATION
- Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial InfarctionClinical Perspective
- (2016) Bobak Heydari et al. CIRCULATION
- Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2016) Franz Duca et al. Circulation-Cardiovascular Imaging
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction
- (2016) Karl-Philipp Rommel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin
- (2015) M. R. Zile et al. CIRCULATION
- Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials
- (2015) Jacob P. Kelly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Think Small and Examine the Constituents of Left Ventricular Hypertrophy and Heart Failure: Cardiomyocytes Versus Fibroblasts, Collagen, and Capillaries in the Interstitium: Figure 1.
- (2015) Erik B. Schelbert et al. Journal of the American Heart Association
- Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy
- (2015) Roger M. Beadle et al. JACC-Heart Failure
- Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
- (2014) Rajesh Garg et al. DIABETES
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
- (2014) M. Senni et al. EUROPEAN HEART JOURNAL
- Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
- (2014) Enrico Conte et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume
- (2013) Christopher A. Miller et al. Circulation-Cardiovascular Imaging
- Strategies and Opportunities for Drug Development in Heart Failure
- (2013) Javed Butler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The disconnect between phase II and phase III trials of drugs for heart failure
- (2013) Muthiah Vaduganathan et al. Nature Reviews Cardiology
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2012) Benjamin A. Steinberg et al. CIRCULATION
- Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
- (2012) Loek van Heerebeek et al. CIRCULATION
- What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
- (2012) Ross T. Campbell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel biomarkers in chronic heart failure
- (2012) Tariq Ahmad et al. Nature Reviews Cardiology
- The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
- (2011) Takanori Yamazaki et al. HYPERTENSION RESEARCH
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- In Vitro Effects of Pirfenidone on Cardiac Fibroblasts: Proliferation, Myofibroblast Differentiation, Migration and Cytokine Secretion
- (2011) Qiang Shi et al. PLoS One
- Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial
- (2011) Roger M Beadle et al. Trials
- Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
- (2010) Khalid Abozguia et al. CIRCULATION
- Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis
- (2010) Andrew S. Flett et al. CIRCULATION
- Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias
- (2010) Duy T. Nguyen et al. HEART RHYTHM
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated With Myocardial Energy Deficiency
- (2009) Thanh T. Phan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Magnetic Resonance Spectroscopy in Myocardial Disease
- (2009) Lucy E. Hudsmith et al. JACC-Cardiovascular Imaging
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now